EDGAR Filing Documents for 0001104659-17-046802

Form 8-K - Current report:

SEC Accession No. 0001104659-17-046802

Filing Date

2017-07-25

Accepted

2017-07-25 16:02:12

Documents

Period of Report

2017-07-25

Items

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-18313_18k.htm	8-K	31425
2	EX-3.1	a17-18313_1ex3d1.htm	EX-3.1	67761
3	EX-3.2	a17-18313_1ex3d2.htm	EX-3.2	191800
	Complete submission text file	0001104659-17-046802.txt		292144

Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453

Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252

Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)